SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-20-009016
Filing Date
2020-03-05
Accepted
2020-03-05 17:29:45
Documents
85
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K sndx-10k_20191231.htm 10-K 3111811
2 EX-4.5 sndx-ex45_574.htm EX-4.5 37550
3 EX-23.1 sndx-ex231_9.htm EX-23.1 2320
4 EX-31.1 sndx-ex311_6.htm EX-31.1 11680
5 EX-31.2 sndx-ex312_8.htm EX-31.2 11698
6 EX-32.1 sndx-ex321_10.htm EX-32.1 11105
7 GRAPHIC gqulovcrs4eg000001.jpg GRAPHIC 43464
  Complete submission text file 0001564590-20-009016.txt   9979233

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT sndx-20191231.xml EX-101.INS 1998052
9 XBRL TAXONOMY EXTENSION SCHEMA sndx-20191231.xsd EX-101.SCH 72557
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20191231_cal.xml EX-101.CAL 53683
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20191231_def.xml EX-101.DEF 234890
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20191231_lab.xml EX-101.LAB 553180
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20191231_pre.xml EX-101.PRE 416196
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37708 | Film No.: 20691835
SIC: 2834 Pharmaceutical Preparations